 Cyclin E is a prognostic marker in breast cancer, its altered expression increased with the increasing stage and grade of the tumor.Low molecular weight cyclin E isoforms have been shown to be of great pathogenetic and prognostic importance for breast cancer.These isoforms are resistant to CKIs, bind with CDK2 more efficiently and can stimulate the cell cycle progression more efficiently.